Priority research areas


  • Investigating the molecular and genetic mechanisms of cardiovascular, blood, endocrine and rheumatic diseases; developing the methods for predicting their occurrence in healthy people; determining the personalized approaches for the prevention and treatment of cardiovascular, blood, rheumatic and endocrine diseases based on genetic maps; developing new cell therapy technologies and implementing nanotechnologies in the treatment of cardiovascular and other diseases.
  • Creating and implementing high-tech cardiac and surgical care system; developing new methods for the surgical treatment of congenital and acquired heart defects, including in newborns and infants, surgical revascularization in coronary heart disease, new high-tech diagnostic methods, surgical and conservative treatment of cardiac rhythm and conduction disorders; new transfusion therapy methods; improving the cardiovascular surgery techniques based on the use of robotic manipulators, minimally invasive and hybrid techniques.
  • Enhancing the high-tech medical care based on science-based standards and an optimal preoperative examination schedule designed to identify the additional risk factors and improve patient preparation for different cardiac surgeries; improving myocardial protection during cardiac surgeries with extracorporeal circulation and off-pump surgeries by ischemic and pharmacological preconditioning, myocardial ischemic postconditioning, preventing peri- and postoperative complications by reducing the ischemia-reperfusion injury.
  • Developing and implementing the system of medical care for patients with arterial hypertension, metabolic syndrome, and diabetes mellitus; new methods of organized and opportunistic screening; establishing the network of pre-hospital and preventive care services; introducing the advanced information and telemedicine technologies into the screening and epidemiological population-based studies; investigating the causes and new treatments for arterial hypertension, blood and endocrine diseases.
  • Improving the scientific framework for the management of high-tech specialized care provided at the Centre; establishing information systems for healthcare quality management based on advanced information and telemedicine technologies; developing the system for the continuous distance education using telemedicine technologies and individualized online learning.
  • Developing and implementing new medical technologies in perinatology aimed at providing high-tech medical care to women suffering from cardiovascular disorders during pregnancy and delivery, prenatal diagnosis and management of congenital cardiovascular abnormalities with subsequent surgical repair of heart defects in newborns.


Уведомляем вас, что в соответствии с Федеральным законом от 06.03.2006 № 35-ФЗ «О противодействии терроризму» в Центре Алмазова введен комплекс дополнительных мер по безопасности, направленный на предотвращение террористических актов. В целях обеспечения безопасности граждан и целостности объектов инфраструктуры при посещении Центра Алмазова проводится дополнительный личный осмотр, осмотр вещей и автотранспорта. Отказ от соблюдения мер по безопасности может послужить причиной недопуска на территорию Центра Алмазова. Просим с пониманием отнестись к введенным мерам по безопасности.

С уважением, Администрация Центра Алмазова